DSV Panalpina A/S
DSV, 855 - SHARE BUYBACK IN DSV PANALPINA A/S
Company Announcement No. 855
On 29 October 2020, we initiated a share buyback programme, as described in Company Announcement No. 842 of 29 October 2020. According to the programme, the company will in the period from 29 October 2020 to 30 April 2021 purchase own shares up to a maximum value of DKK 6,000,000,000 and no more than 12,000,000 shares, corresponding to 5.22% of the share capital at commencement of the programme. The programme has been implemented in accordance with Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour rules.
Trading day | Number of shares bought back | Average transaction price | Amount DKK | ||||
Accumulated trading for days 1-43 | 1,962,306 | 1,019.42 | 2,000,421,077 | ||||
44: | 4 January 2021 | 12,307 | 1,038.03 | 12,775,034 | |||
45: | 5 January 2021 | 100,000 | 1,036.52 | 103,652,460 | |||
46: | 6 January 2021 | 100,000 | 1,015.00 | 101,500,360 | |||
47: | 7 January 2021 | 100,000 | 1,007.61 | 100,761,450 | |||
48: | 8 January 2021 | 94,538 | 1,000.92 | 94,625,240 | |||
Accumulated trading for days 1-48 | 2,369,151 | 1,018.82 | 2,413,735,620 |
As at today, DSV Panalpina A/S holds a total of 4,291,667 shares of a nominal value of DKK 1 in DSV Panalpina A/S, corresponding to 1.87% of the total number of issued shares of 230,000,000.
The details of each transaction made under the share buyback programme are published on investor.dsv.com .
Any questions may be addressed to Executive Vice President, Investor Relations, Flemming Ole Nielsen, tel. +45 43 20 33 92.
Yours sincerely,
DSV Panalpina A/S
Attachment
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S26.1.2021 12:47:12 CET | Press release
Genmab Announces 2020 Net Sales of DARZALEX® (daratumumab)
Tryg A/S26.1.2021 12:03:20 CET | Press release
Corporate Responsibility report 2020
Evli Bank Plc26.1.2021 12:01:49 CET | Press release
Evli Bank Plc - Managers' Transactions
Uponor Corporation26.1.2021 12:01:39 CET | Press release
Proposals by Uponor Nomination Board to the Annual General Meeting 2021
Sveriges Riksbank26.1.2021 11:31:37 CET | Press release
RESULT OF RIKSBANK REVERSED AUCTIONS SEK MUNICIPAL BONDS
Interop Technologies26.1.2021 11:05:35 CET | Press release
RCS users to grow 294% by 2024, driving new revenue for mobile operators
Active Biotech26.1.2021 11:01:35 CET | Press release
Active Biotech’s rights issue heavily oversubscribed
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom